Stephen Chambers
InvestorGeneral Partner at SOSV
New York, New York
Writes $100K – $2M checks · typically $1M
About
Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.
Experience
- SOSVManaging Director & General Partner at SOSV NYcurrent2020 — presentNew York, United States
- Imperial College LondonRoyal Society Entrepreneur in Residence2019 — 2021Greater London, England, United Kingdom
- Bio-startCo Founder2016 — 2018Greater London, England, United Kingdom
- SynbiCITECEO2014 — 2018Greater London, England, United Kingdom
- London DNA FoundryAdvisory Board Member2014 — 2018Greater London, England, United Kingdom
- AbproCo Founder2008 — 2013Lexington, MA, USA
- Vertex PharmaceuticalsDirector of Gene Expression1990 — 2007Cambridge, MA, USA
Skills & more
Mentoring1StartupsClinical DevelopmentProtein ExpressionProtein EngineeringMonoclonal AntibodiesBusiness DevelopmentAutomationDesign of Experiments (DOE)Technological InnovationSynthetic BiologyProject Mangement
+12 more
InvestmentFundraisingInvestmentsBiochemistryBiotechnologyProtein ChemistryMolecular BiologyDrug DiscoveryStart-upsCell CultureLifesciencesCell BiologyFrom Stephen's professional profile.
Colleagues at SOSV
Network2
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Chambers?
- Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.
- Where does Stephen Chambers work?
- Stephen Chambers is General Partner at SOSV.
- What check size does Stephen Chambers write?
- Stephen Chambers typically writes checks of $100K – $2M.
- Where did Stephen Chambers go to school?
- Stephen Chambers studied at University of Warwick (PhD, Molecular Biology); University of Birmingham (MS, Biotechnology); Bangor University (BS, Biochemistry).
Same school
Also attended University of Warwick154
MariaInvestor at InvestinorChen Yang SiaGeneral Counsel at Golden Gate VenturesMichael CheungInvestment at Makers FundChen YangAdvisor at Golden Gate VenturesSvetlana BenderVice President, Artificial Intelligence & Behavioral Science at Flare Capital PartnersDr. Mazin AlzaidiGeneral Partner at STV
+ 148 more
Also attended University of Birmingham91
Hal TilyVenture Partner at Rackhouse Venture Management LpAlexa TanAssociate, ESG & Impact at Openspace VenturesSikander ChahalPrincipal at TRANSCENDSunir KapoorNon-Executive Chairman at Kibo VenturesChloe LeggeInvestor at Extantia CapitalHelen LyuEvents Lead at The Spartan Group
+ 85 more
Also attended Bangor University6
Stephen Antwi-AsimengSenior Fund Advisor at Wangara Green VenturesSimon ThorneSenior Talent Manager at SAGANAJohn SutherlandOperating Partner at Frog CapitalMary AkpobomeInvestor at Rising Tide Africa (RTA)Erick RinnerPartner at Impact Expansion Management SarlSohail MalikInvestor at Saudi Aramco Energy Ventures
Shared employers
Also worked at Imperial College London132
Madison LenormandInvestor at DaphniAlptugInvestment Team at Hummingbird VenturesItxaso del PalacioGeneral Partner at Notion CapitalMichelle KwokPrincipal at Draper AssociatesMercedes TuinPartner at Heran PartnersStephanie MorrisPrincipal at Artesian
+ 126 more
Also worked at Abpro1
Also worked at Vertex Pharmaceuticals21
Bruce SachsInvestor at CRV (Charles River Ventures)Jesper GromadaInvestor at Third Rock VenturesAlexandra CantleyManaging Partner at Polaris PartnersShwen GweeDigital Pharma Advisor at Excelerate Health VenturesLloyd CarneyStrategic Advisor at Vertical Venture PartnersSumia ShaikhHead of Platform at New York Life Ventures
+ 15 more






















.png)

















